Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MICALL2 Antikörper (AA 132-741)

MICALL2 Reaktivität: Human WB, ELISA, FACS, IHC Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN7599972
  • Target Alle MICALL2 Antikörper anzeigen
    MICALL2 (MICAL-Like 2 (MICALL2))
    Bindungsspezifität
    • 8
    • 2
    • 1
    AA 132-741
    Reaktivität
    Human
    Wirt
    • 10
    Kaninchen
    Klonalität
    • 10
    Polyklonal
    Konjugat
    • 5
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser MICALL2 Antikörper ist unkonjugiert
    Applikation
    • 10
    • 9
    • 8
    • 8
    • 2
    Western Blotting (WB), ELISA, Flow Cytometry (FACS), Immunohistochemistry (IHC)
    Verwendungszweck
    Anti-MICALL2 Antibody Picoband®
    Kreuzreaktivität (Details)
    No cross-reactivity with other proteins.
    Produktmerkmale
    Anti-MICALL2 Antibody Picoband® (ABIN7599972). Tested in ELISA, IHC, WB, Flow Cytometry applications. This antibody reacts with Human. The brand Picoband indicates this is a premium antibody that guarantees superior quality, high affinity, and strong signals with minimal background in Western blot applications. Only our best-performing antibodies are designated as Picoband, ensuring unmatched performance.
    Aufreinigung
    Immunogen affinity purified.
    Immunogen
    E.coli-derived human MICALL2 recombinant protein (Position: K132-Q741).
    Isotyp
    IgG
    Top Product
    Discover our top product MICALL2 Primärantikörper
  • Applikationshinweise
    Western blot, 0.25-0.5 μg/mL, Human
    Immunohistochemistry(Paraffin-embedded Section), 2-5 μg/mL, Human
    Flow Cytometry (Fixed), 1-3 μg/1x106 cells, Human
    ELISA, 0.1-0.5 μg/mL, -
    1. Sakane, A., Yano, T. A., Uchihashi, T., Horikawa, K., Hara, Y., Imoto, I., ... & Sasaki, T. (2021). JRAB/MICAL-L2 undergoes liquid-liquid phase separation to form tubular recycling endosomes. Communications biology, 4(1), 551. 2. Zhu, L. Y., Zhang, W. M., Yang, X. M., Cui, L., Li, J., Zhang, Y. L., ... & Zhang, Z. G. (2015). Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition. Cancer letters, 363(1), 71-82. 3. Min, P., Zhao, S., Liu, L., Zhang, Y., Ma, Y., Zhao, X., ... & Du, J. (2019). MICAL-L2 potentiates Cdc42-dependent EGFR stability and promotes gastric cancer cell migration. Journal of cellular and molecular medicine, 23(6), 4475-4488.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Rekonstitution
    Adding 0.2 mL of distilled water will yield a concentration of 500 μg/mL.
    Konzentration
    500 μg/mL
    Buffer
    Each vial contains 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na2HPO4.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    At -20°C for one year from date of receipt. After reconstitution, at 4°C for one month.
    It can also be aliquotted and stored frozen at -20°C for six months. Avoid repeated freezing and thawing.
  • Target
    MICALL2 (MICAL-Like 2 (MICALL2))
    Andere Bezeichnung
    MICALL2 (MICALL2 Produkte)
    Hintergrund

    Synonyms: Mediator of RNA polymerase II transcription subunit 9, Mediator complex subunit 9, MED9, MED25,

    Tissue Specificity: Expressed in fetal brain, fetal lung, fetal liver, heart, brain, placenta, lung, liver, muscle, kidney and pancreas.

    Background: Enables filamin binding activity. Involved in positive regulation of protein targeting to mitochondrion. Predicted to be located in several cellular components, including bicellular tight junction, neuron projection, and recycling endosome. Predicted to colocalize with stress fiber.

    Molekulargewicht
    109 kDa
    Gen-ID
    79778
Sie sind hier:
Chat with us!